CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Skip
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
 
Skip the Contents menu

Contents

Skip the Resources menu

Resources



U.S. Department of Health and Human Services
 
 

TB Notes Newsletter

Return to TB Notes 1, 2006 Main Menu

This is an archived document. The links and content are no longer being updated.

No. 1, 2006

NEW CDC PUBLICATIONS

CDC. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR 2005; 54 (RR-12): 1-81.

CDC. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR 2005; 54 (RR-17): 1-141.

CDC. Guidelines for the investigation of contacts of persons with infectious tuberculosis: recommendations from the National Tuberculosis Controllers Association and CDC. MMWR 2005; 54 (RR-15): 1-37.

CDC. Guidelines for using the QuantiFERON-TB Gold Test for detecting Mycobacterium tuberculosis infection, United States. MMWR 2005; 54 (RR-15): 49-55.

CDC. Mycobacterium tuberculosis transmission in a newborn nursery and maternity ward—New York City, 2003. MMWR 2005; 54 (50): 1280-1283.

Clark CM, Li J, Driver CR, and Munsiff SS. Risk factors for drug-resistant tuberculosis among non-US-born persons in New York City. International Journal of Tuberculosis and Lung Disease 2005; 9(9): 964-9.

Fujiwara PI, Clevenbergh P, and Dlodlo RA. Management of adults living with HIV/AIDS in low-income, high-burden settings, with special reference to persons with tuberculosis. International Journal of Tuberculosis and Lung Disease 2005; 9(9): 946-58.

Ijaz K, Jereb J, Lambert L, Bower W, Spradling P, McElroy P, Iademarco M, Navin T, and Castro K. Severe or fatal liver injury in 50 patients in the United States taking rifampin and pyrazinamide for latent tuberculosis infection. Clinical Infectious Diseases 2006; 42: 346-355.

Lee LM, Lobato MN, Buskin SE, Morse A, Costa S. Low adherence to guidelines for preventing TB among persons with newly diagnosed HIV infection, United States. International Journal of Tuberculosis and Lung Disease 2006; 10(2): 209-214.

Maloney SA, Fielding KL, Laserson KF, et al. Assessing the performance of overseas tuberculosis screening programs: a study among US-bound immigrants in Vietnam. Arch Intern Med 2006; (2)166: 234-240.

Miller TL, Hilsenrath P, Lykens K, McNabb SJ, Moonan PK, Weis SE. Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States. Annals of Epidemiology 2005 Oct. 20 [Epub ahead of print].

Nelson LJ, Naik Y, Tsering K and Cegielski JP. Population-based risk factors for tuberculosis and adverse outcomes among Tibetan refugees in India, 1994-1996. International Journal of Tuberculosis and Lung Disease 2005; 9 (9): 1018-26.

Shah NS, Harrington T, Huber M, Wellnitz C, Fridrych S, Laserson K, Gonzalez IM, and Ijaz K. Increased reported cases of tuberculosis among children younger than 5 years of age, Maricopa County, Arizona, 2002-2003. The Pediatric Infectious Diseases Journal 2006; 25: 151-155.

Weiner M, Benator D, Peloquin CA, Burman W, Vernon A, Engle M, Khan A, and Zhao Z. Evaluation of the drug interaction between rifabutin and efavirenz in patients with HIV infection and tuberculosis. Clinical Infectious Diseases 2005; 41(9): 1343-9.

White MC, Tulsky JP, Menendez E, Goldenson J, and Kawamura LM. Incidence of TB in inmates with latent TB infection: 5-year follow-up. American Journal of Preventive Medicine 2005; 29(4): 295-301.

 

Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention

 

 
Back to Top of Page


If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov


Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA | USA.gov
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov